| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-11 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-07 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.25 | 1e-06 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-06 |